Comorbidities and socioeconomic status are predictors of survival in children and young adults with Burkitt lymphoma

Leuk Lymphoma. 2021 Nov;62(11):2804-2807. doi: 10.1080/10428194.2021.1932873. Epub 2021 Jun 1.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Burkitt Lymphoma* / diagnosis
  • Burkitt Lymphoma* / epidemiology
  • Child
  • Cyclophosphamide
  • Humans
  • Social Class
  • Young Adult

Substances

  • Cyclophosphamide